drugset / Trial / NCT07836140

A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.

NCT07836140 ↗

Phase 2 Completed 60 enrolled Second Affiliated Hospital of Soochow University
RandomizedParallel-groupOpen-labelBasic science

Summary

An Investigator-Initiated, Randomized, Open-Label, Active-Controlled Study Comparing the Effects of BGM0504 Injection versus Semaglutide Injection on Insulin Sensitivity and Body Weight in Obese Subjects

Timeline

Start
2024-04-22
Primary completion
2025-04-25
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BGM0504 Unknown — Subcutaneous
Comparator Semaglutide Peptide — Subcutaneous

Indications